Glaucoma: Current treatment and impact of advanced drug delivery systems

Life Sciences
Khushwant S YadavSushmita Sharma

Abstract

The human eye being a complex and a very sensitive organ makes the drug delivery task challenging. An increase in the intra-ocular pressure at the aqueous humour leads to glaucoma which is not only indecipherable but can also be the reason of blindness for many. The presently available marketed formulations using anti-glaucoma drugs have issues of either difficulty in crossing the blood- retinal barrier or lower systemic bioavailability. Hence, the drugs having lower therapeutic index would need to be administered frequently, which eventually lead to deposition of concentrated solutions at ocular site, producing toxic effects and cellular damage to the eye. To overcome these drawbacks the novel drug delivery systems like In-situ gels, liposomes, niosomes, hydrogel, dendrimers, nanoparticles, solid lipid nanoparticles, Microneedles or ocular inserts play an important role to enhance the therapeutic efficacy of the anti-glaucomic drugs. The present review briefs the current treatments in terms of drugs used and in detail the impact of utilizing the above mentioned novel drug delivery systems in the treatment of glaucoma.

References

Jan 1, 1979·Ophthalmology·R P WilsonG L Spaeth
Apr 15, 1985·American Journal of Ophthalmology·M J MartinE L Diamond
Jul 15, 1985·American Journal of Ophthalmology·F T FraunfelderM W Dreis
Aug 1, 1965·Journal of Molecular Biology·A D BanghamJ C Watkins
Aug 1, 1983·American Journal of Epidemiology·M C Leske
Mar 1, 1995·Journal of Pharmaceutical Sciences·S Kumar, K J Himmelstein
Oct 29, 1998·The New England Journal of Medicine·W L Alward
Nov 26, 1999·Ophthalmology·A Da MataC S Foster
Jan 9, 2001·Drug Development and Industrial Pharmacy·E DimitrovaE Minkov
Apr 3, 2001·Expert Opinion on Investigational Drugs·C Lindén
Sep 3, 2002·Survey of Ophthalmology·Carol B TorisCarl B Camras
Oct 9, 2002·Archives of Ophthalmology·Anders HeijlUNKNOWN Early Manifest Glaucoma Trial Group
Mar 27, 2003·Investigative Ophthalmology & Visual Science·John H K LiuRobert N Weinreb
Oct 12, 2004·Lancet·Jannis KountourasDimitrios Chatzopoulos
Jan 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Th F Vandamme, L Brobeck
Mar 26, 2005·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·David A Lee, Eve J Higginbotham
Nov 3, 2005·Advanced Drug Delivery Reviews·Tsutomu YasukawaHideya Kimura
Nov 18, 2005·Advanced Drug Delivery Reviews·Anne-Marie CaminadeJean-Pierre Majoral
Feb 21, 2006·The British Journal of Ophthalmology·H A Quigley, A T Broman
Aug 29, 2007·Investigative Ophthalmology & Visual Science·Jason JiangMark R Prausnitz
Oct 27, 2007·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Li XinmingLiao Liewen
Feb 16, 2008·Drug Discovery Today·Sanjeeb K SahooS Krishnakumar
May 22, 2008·Expert Opinion on Drug Delivery·Jaleh BararYadollah Omidi
Jun 24, 2008·Current Eye Research·A S Mundada, B K Shrikhande
Nov 4, 2008·Pharmaceutical Research·Jason JiangMark R Prausnitz
Dec 17, 2008·Survey of Ophthalmology·Anne L Coleman, Stefano Miglior
Mar 3, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chi H LeeYugyung Lee
Apr 1, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ramesh C NagarwalJ K Pandit
Aug 4, 2009·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Basavaraj K NanjwadeVeerendra K Nanjwade
Nov 6, 2009·European Journal of Medicinal Chemistry·Grégory SpataroAnne-Marie Caminade
Oct 1, 2008·Indian Journal of Pharmacology·S K GuptaRohit Saxena
Jan 9, 2010·Journal of Drug Targeting·Himanshu GuptaSanyog Jain
Mar 2, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Taís GratieriRenata Fonseca Vianna Lopez
Sep 28, 2010·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Marco A ZarbinRobert Ritch
Dec 21, 2010·Drug Discovery Today·Thilini Rasika ThrimawithanaRaid Ghassan Alany
Apr 9, 2011·Eye·E LavikY H Kwon
Aug 30, 2011·Human Molecular Genetics·Janey L WiggsUNKNOWN GENEVA Consortium
Jul 1, 2010·Journal of Advanced Pharmaceutical Technology & Research·Anita KumariGarima Garg
Nov 17, 2012·Drug Development and Industrial Pharmacy·Djamila AchouriVéronique Andrieu

❮ Previous
Next ❯

Citations

Oct 22, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Ying ShenYaru Sun
Dec 31, 2019·Recent Patents on Drug Delivery & Formulation·Zufika QamarSanjula Baboota
Aug 24, 2019·Expert Opinion on Therapeutic Patents·Alessandro Bonardi, Claudiu T Supuran
Sep 6, 2019·Expert Opinion on Therapeutic Patents·Alessio Nocentini, Claudiu T Supuran
Oct 28, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fidiniaina Rina JulianaMeihao Sun
Apr 9, 2020·Frontiers in Bioengineering and Biotechnology·Courtney R LynchViness Pillay
Aug 7, 2019·Expert Opinion on Therapeutic Patents·Paolo GuglielmiGiovanna Poce
Dec 4, 2019·PeerJ·Mingxuan Wang, Yajuan Zheng
Aug 13, 2020·Drug Delivery and Translational Research·Xuefei LiXianggen Wu
Jul 28, 2020·Expert Opinion on Pharmacotherapy·Wesam Shamseldin ShalabyL Jay Katz
Aug 11, 2020·Journal of Ophthalmology·Barbara Cvenkel, Miriam Kolko
Nov 24, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Nada M El HoffySeham A Elkheshen
Dec 12, 2020·Computerized Medical Imaging and Graphics : the Official Journal of the Computerized Medical Imaging Society·Bala PrabhakarKhushwant S Yadav
Dec 31, 2020·Pharmaceutics·Ognjenka RahićEdina Vranić
Oct 31, 2020·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Chen QinQuankui Lin
Feb 14, 2021·International Journal of Biological Macromolecules·B N KumaraK Sudhakara Prasad
Jul 21, 2020·Heliyon·Eleazar Uchenna IkonneEziuche Amadike Ugbogu
May 16, 2021·International Journal of Pharmaceutics·Blanca Lorenzo-VeigaHakon Hrafn Sigurdsson
May 30, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Mary Ann Stepp, A Sue Menko
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jiaqi LiuSongli Shi
Aug 18, 2021·International Journal of Pharmaceutics·Katarzyna B WróblewskaIzabela Muszalska-Kolos
Sep 18, 2020·Current Pharmaceutical Design·Karthikeyan KesavanVal C Sheffield
Aug 27, 2021·The British Journal of Ophthalmology·Ari StonerBrent Siesky
Jul 21, 2020·Journal of Medicinal Chemistry·Anna Duran-CorberaXavier Rovira
Jun 14, 2020·La Revue de médecine interne·T Bejan-Angoulvant, D Angoulvant
Feb 11, 2020·Current Stem Cell Research & Therapy·Nanxin LiuGang Fu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Critical Reviews in Therapeutic Drug Carrier Systems
Gagandeep GoyalAmit Kumar Goyal
Macromolecular Bioscience
Shengyan LiuFrank X Gu
Critical Reviews in Therapeutic Drug Carrier Systems
Indu Pal Kaur, Shilpa Kakkar
© 2022 Meta ULC. All rights reserved